Cancer drug developer NH Theraguix was incubated by Satt Pulsalys to advance a nanoparticle-based drug for solid tumours that works by enhancing the efficacy of radiotherapy treatment and MRI scans.

Dongfeng Motor has led a nine-figure series A3 round for AutoX, adding to at least $43m in capital previously raised from investors including MediaTek and SAIC Motor.

NavInfo led a series B round that increased the advanced driver-assistance system developer's funding to $20m over the past six months.

Sabic has equipped Mallinda with funding as the CU Boulder-founded thermoset resins provider gears up for the launch of its first commercial product.

NUI Maynooth spinout Avectas has added capital to converted equity previously supplied by therapeutics developer Adapt Pharma among others.

UVA’s seed fund and corporate venturing unit PharmStandard Ventures featured in topical dry eye syndrome peptide spinout TearSolutions' financing round, taking its total to $21.5m.

Queen’s University Belfast speech recognition technology spinout Liopa is working on a product that analyses lip movements to provide more robust analysis in noisy environments.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The identity verification software provider will invest up to $2m in each deal through its newly formed Okta Ventures fund, with Trusted Key its first portfolio company.

Sinopharm Capital helped supply funding to orthopaedic-focused device maker Suzhou and Science Technology Development, with the latter eyeing new products in areas including sports medicine.